Therapy News and Research

RSS

Four major U.S. ethnic groups less likely to have cholesterol controlled

Compared with non-Hispanic whites, non-Hispanic blacks and Hispanics who qualify for cholesterol-lowering drug treatment are less likely to have their “bad” LDL cholesterol controlled to recommended levels, researchers reported at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Atorvastatin slows down mental decline and improves depressive symptoms in people with Alzheimer’s disease

The cholesterol-lowering drug atorvastatin slowed down mental decline and improved depressive symptoms in people with Alzheimer’s disease, according to a small pilot study reported at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Women with arrhythmias may also benefit from implantable cardioverter-defibrillators

A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD), reported researchers at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

New treatments for eating disorders

Clinical eating disorders have one of the highest mortalities of any psychiatric category. They can be long lasting and life blighting. However, too often they are thought of by the general public, and sometimes even by health care professionals, either as trivial and perhaps glamorous or as rare and extraordinary.

11 Nov 2004

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc., has been allowed a patent by the Canadian Patent Office entitled "Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase."

10 Nov 2004

UT Southwestern Moncrief Cancer Center treats patients with TomoTherapy

UT Southwestern Moncrief Cancer Center this week began treating patients with a TomoTherapy system utilizing image-guided radiation therapy (IGRT). Moncrief is the first cancer center in Texas to offer radiation treatment delivered by the TomoTherapy Hi-Art System.

10 Nov 2004

Dietary supplement DHEA could play a role in reducing abdominal fat in elderly men and women

Preliminary research indicates that the dietary supplement DHEA could play a role in reducing abdominal fat in elderly men and women with age-related decreases in DHEA levels, according to a study in the November 10 issue of JAMA.

10 Nov 2004

Heart jacket effective treatment for heart failure

The concept is simple: to halt deterioration of the heart muscle, wrap it in a mesh-like net to prevent further enlargement in patients with heart failure. It's like a jacket for the heart.

10 Nov 2004

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease, according to results of a study including UT Southwestern Medical Center at Dallas researchers.

9 Nov 2004

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.

9 Nov 2004

BiDil demonstrates significant improvement in survival rates in African American heart failure patients

"African Americans suffer disproportionately from heart failure and until A-HeFT have been underrepresented in heart failure trials," said Malcolm Taylor, M.D., Chair of the Association of Black Cardiologists Committee on Heart Failure. "A-HeFT represents a significant step forward in addressing these disparities."

9 Nov 2004

Scientists have developed a fast and safe method for collecting heart stem cells from small amounts of biopsied heart tissue

In human and animal studies, scientists at Johns Hopkins have developed a fast and safe method for collecting heart stem cells from remarkably small amounts of biopsied heart tissue (15 mg or less), and growing the cells in the lab to get more.

9 Nov 2004

Sharply increased demand for artemether-lumefantrine, used to treat malaria, is likely to result in a shortage

Sharply increased demand for artemether-lumefantrine, an artemisinin-based combination therapy (ACT) used to treat malaria, is likely to result in a shortage from now until at least March 2005. ACTs are currently the most effective medicines available to treat falciparum malaria -- the deadliest form of the disease.

9 Nov 2004

ACE inhibitors not needed for many heart disease patients

Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).

8 Nov 2004

MRI technique for measuring blood volume helps distinguish between abscesses and tumors in the brain

Dynamic susceptibility contrast (DSC) MRI allows physicians to differentiate between cerebral abscesses—inflamed areas in the brain caused by infection—and malignant brain tumors without surgery, says a new preliminary study by researchers from Duke University Medical Center in Durham, NC.

8 Nov 2004

Doctors must choose and manage implanted cardiac defibrillators patients carefully

Implanted devices that can shock a failing heart back into regular rhythm do an excellent job of keeping patients alive, two new University of Michigan studies find.

8 Nov 2004

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

A major Canadian-led global study has found that an inexpensive anti-blood-clotting drug significantly reduces death and repeat heart attacks without increasing the risk of stroke.

8 Nov 2004

D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders

A tuberculosis drug called D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders, according to research by scientists at Emory University School of Medicine and the Center for Behavioral Neuroscience (CBN).

8 Nov 2004

Lipid Sciences' selective delipidation process demonstrates enhanced ability in removing cholesterol from cells

Lipid Sciences announced today that researchers have successfully used the Company's proprietary "selective delipidation" process to create a modified form of HDL ("good cholesterol") that is known to be more effective in reverse cholesterol transport, the body's natural process for removing lipids from arterial plaque.

8 Nov 2004

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance.

8 Nov 2004

Therapy News and Research

Four major U.S. ethnic groups less likely to have cholesterol controlled

Atorvastatin slows down mental decline and improves depressive symptoms in people with Alzheimer’s disease

Women with arrhythmias may also benefit from implantable cardioverter-defibrillators

New treatments for eating disorders

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

UT Southwestern Moncrief Cancer Center treats patients with TomoTherapy

Dietary supplement DHEA could play a role in reducing abdominal fat in elderly men and women

Heart jacket effective treatment for heart failure

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

BiDil demonstrates significant improvement in survival rates in African American heart failure patients

Scientists have developed a fast and safe method for collecting heart stem cells from small amounts of biopsied heart tissue

Sharply increased demand for artemether-lumefantrine, used to treat malaria, is likely to result in a shortage

ACE inhibitors not needed for many heart disease patients

MRI technique for measuring blood volume helps distinguish between abscesses and tumors in the brain

Doctors must choose and manage implanted cardiac defibrillators patients carefully

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders

Lipid Sciences' selective delipidation process demonstrates enhanced ability in removing cholesterol from cells

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News